Power illness teaching firm Cecelia Well being closes $13M

Chronic disease coaching company Cecelia Health closes $13M

Cecelia Well being, a digital diabetes and continual illness administration startup, has raised $13 million in Collection B funding. Rittenhouse Ventures and Endo Traders co-led the spherical, which additionally noticed participation from Boston Millennia Companions, SustainVC, G100 Capital and others.


The corporate was initially based as Fit4D, and centered on entry to licensed diabetes educators (CDE) for scalable one-on-one teaching. It rebranded itself as Cecelia Well being in January 2019 (after the CDE who CEO and founder David Weingard mentioned impressed him to begin the corporate). It expanded its focus past diabetes and into further continual circumstances.

The corporate companions with well being plans, self-insured employers, medical gadget firms and Pharma organizations to develop and ship digital teaching that helps illness administration and therapy adherence. Every affected person receives a customized administration plan, whereas the scientific coaches themselves are supported by a know-how platform that helps observe affected person progress, highlights purple flags and encourages greatest practices.

The corporate mentioned it has logged greater than 1 million distant affected person interactions, and like different digital care suppliers is seeing elevated demand following COVID-19. Only a week in the past, it introduced its function in a $5 million grant awarded to the Jaeb Heart for Well being Analysis Basis from the Helmsley Charitable Belief to judge a Cecelia Well being-developed digital specialty clinic mannequin.


The corporate mentioned that it might be utilizing the funds to scale and speed up market adoption of its digital teaching and telemedicine providers.

“The market alternative and demand for Cecelia Well being’s telehealth options has grown exponentially for the reason that onset of COVID-19 as a consequence of our demonstrated observe file for considerably bettering the well being outcomes and high quality of life for folks dwelling with diabetes and different continual circumstances,” David Weingard, founder and CEO of Cecelia Well being, mentioned in an announcement.

“The brand new funding capital from Rittenhouse, Endo, Boston Millennia, SustainVC and G100, and the chief entry they’ll present to new well being plan, pharmaceutical and medical gadget firms and self-insured employers will allow us to speed up our mission to remodel lives at scale,” he mentioned.


Tech-enabled diabetes and continual illness teaching is available in quite a lot of completely different varieties. Among the many extra outstanding names are Onduo, Virta, Livongo and Omada, every of which mix stay teaching providers with linked monitoring gadgets and a affected person app. The latter two firms specifically have been making noise currently, whether or not that be by way of new acquisitions to broaden into completely different illness administration areas or mergers with one of many largest suppliers of telehealth and digital care.


“We’re keen to begin connecting Cecelia Well being with healthcare organizations in our community as they proceed to alter the panorama of continual situation administration,” David Niles, president of G100 Capital, mentioned in an announcement. “Our funding in Cecelia Well being is pushed by our confidence in its group and its confirmed observe file of delivering superior affected person outcomes, and we consider this new capital will allow them to have a big affect on the healthcare business at giant.”

Supply hyperlink

Be the first to comment

Leave a Reply